To investigate this phenomenon more comprehensively, a future point of interest would be to assess mutant IDH chondrosarcoma mitochondria β-oxidative capacity and acylcarnitine flux metabolism by carbon isotope labeling. This evidence concerns the gene IDH2 and chondrosarcoma.